This summary was created by AI, based on 1 opinions in the last 12 months.
According to the reviews, Salona Global Medical (SGMD-X) has achieved its desired revenue base and is starting to cross-sell products. The new management has a focus on profitability, and technology is expected to aid in this goal. Despite a significant decline in stock value, experts believe this company offers amazing value right now.
Has owned stock in the company before. Company executing well and is well managed. Founder is experienced in business. Expecting revenue to grow. Margins growing fast.
Believes management team is excellent. Company growing organically with a mix of M&A. Trading at 1.2x sales (peers trade at 4-8x sales). Expecting share price to rise significantly.
Salona Global Medical is a Canadian stock, trading under the symbol SGMD-X on the TSX Venture Exchange (SGMD-CV). It is usually referred to as TSXV:SGMD or SGMD-X
In the last year, there was no coverage of Salona Global Medical published on Stockchase.
Salona Global Medical was recommended as a Top Pick by on . Read the latest stock experts ratings for Salona Global Medical.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Salona Global Medical In the last year. It is a trending stock that is worth watching.
On 2024-01-12, Salona Global Medical (SGMD-X) stock closed at a price of $0.22.
Achieved desired revenue base and starting to cross-sell products. New management focus on profitability, and technology should help. Amazing value right now.